Skip to main content
Electromed, Inc. (ELMD)
NYSEAMERICAN: ELMD · IEX Real-Time Price · USD
14.62
-0.17 (-1.15%)
May 31, 2024, 4:00 PM EDT - Market closed

Electromed Revenue

Electromed had revenue of $53.50M in the twelve months ending March 31, 2024, with 17.00% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $13.87M with 14.94% year-over-year growth. In the fiscal year ending June 30, 2023, Electromed had annual revenue of $48.07M with 15.38% growth.

Revenue (ttm)
$53.50M
Revenue Growth
+17.00%
P/S Ratio
2.37
Revenue / Employee
$314,682
Employees
170
Market Cap
126.55M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 202348.07M6.41M15.38%
Jun 30, 202241.66M5.90M16.51%
Jun 30, 202135.76M3.29M10.12%
Jun 30, 202032.47M1.17M3.74%
Jun 30, 201931.30M2.99M10.57%
Jun 30, 201828.31M2.45M9.46%
Jun 30, 201725.86M2.87M12.48%
Jun 30, 201622.99M3.58M18.46%
Jun 30, 201519.41M3.92M25.31%
Jun 30, 201415.49M383.45K2.54%
Jun 30, 201315.10M-4.42M-22.64%
Jun 30, 201219.52M520.98K2.74%
Jun 30, 201119.00M4.70M32.86%
Jun 30, 201014.30M1.31M10.04%
Jun 30, 200913.00M4.25M48.52%
Jun 30, 20088.75M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
American Well 254.57M
CytomX Therapeutics 119.18M
Adagene 18.11M
DBV Technologies 14.94M
NovaBay Pharmaceuticals 14.23M
Adlai Nortye 5.00M
I-Mab 3.90M
Revenue Rankings

ELMD News

More News